Medical Technologies is experienced in conducting complex, intensive early and late stage clinical research and bioequivalence clinical trials.

We offer:

  • Choice of clinical reseach sites
  • Possibility to open several sites of the network for proven enrollment
  • First feedback about the study and signing of a CDA within 12-24 hours
  • Feasibility completion in the shortest possible time (3-5 business days)
  • Commercial proposal within 3 business days
  • Experienced and dedicated staff 
  • Pull of KOLs to participate as PIs and a clear division of responsibilities within a study team
  • Proven expertise in early phase studies
  • Experience in phase II-III studies
  • Preparation of the unit for the start-up: pre-screening of subjects before the start-up, speedy and high-quality enrollment starting from the first day after the start up
  • Screening within 1-2 days due to a big database of volunteers that is maintained on the ongoing basis
  • High-quality recruitment of patients: established relationship with and an implemented motivation system of referrals, constant management of referrals
  • Protocol expertise
  • Prepared project-specific source documentation templates 
  • Annual equipment check, contracts with main vendors
  • Possibility to provide necessary documentation within 12 hours
  • State-of-the-art facilities
  • Implemented quality management system
  • Fast agreement signature process (not longer than 1-2 weeks)
  • LEC review upon request
  • LEC review before MoH approval which helps to speed up site start-up period of the trial
  • Commitment to quality and the principles of Good Clinical Practice and applicable legislation
  • Capacity to carry out multiple, complex, procedurally intensive studies simultaneously
  • Customized solutions in the drug development process and quick response for the queries

What is more, we provide stable and predicted enrollment of subject even into clinical trials of early phases. In case of competitive enrollment our sites enroll 2 or 3 times more patients than conventional sites. Several times our sites were global, European and local top enrollers.

We are interested in long-term relationship with our clients, that is why we try to make all possible efforts to perform clinical trials on time and with great quality.